SCHEMBL25976232

SCHEMBL25976232

Cc1ccc(S(=O)(=O)OCCOCCC(C)(C)C)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
STAT3 P40763 2/20 0.38
GAA P10253 1/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP13 P45452 1/20 0.36
VDR P11473 1/20 0.36
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28341552 1.00 ALDH1A1 (0.44) ALDH1A1CA12CA1CA9MEN1
SCHEMBL28880308 1.00 ALDH1A1 (0.44) ALDH1A1CA12CA1CA9MEN1
SCHEMBL17971061 1.00 ALDH1A1 (0.44) ALDH1A1CA12CA1CA9MEN1
SCHEMBL22326291 0.91 ALDH1A1 (0.42) ALDH1A1CA12CA1CA9MEN1
SCHEMBL6002078 0.90 ALDH1A1 (0.43) ALDH1A1CA12CA1CA9MEN1
SCHEMBL4379133 0.88 ALDH1A1 (0.53) ALDH1A1CA12CA1CA9MEN1
SCHEMBL18644929 0.88 ALDH1A1 (0.53) ALDH1A1CA12CA1CA9MEN1
SCHEMBL18613994 0.88 ALDH1A1 (0.53) ALDH1A1CA12CA1CA9MEN1
SCHEMBL922407 0.88 ALDH1A1 (0.53) ALDH1A1CA12CA1CA9MEN1
SCHEMBL478342 0.88 ALDH1A1 (0.53) ALDH1A1CA12CA1CA9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250091-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250091-A1 ASGPR CELL SURFACE RECEPTOR BINDING COMPOUNDS AND CONJUGATES ASGR1, LAMP2, FCGR2A ALDH1A1 2955/4885CA12 1732/4885CA1 3349/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.